Rationale: Although multiple lines of evidence suggest that variable expression of the cardiac sodium channel gene SCN5A plays a role in susceptibility to arrhythmia, little is known about its transcriptional regulation.
N ormal function of the sodium channel encoded by SCN5A is critical to initiation of the action potential and its propagation in atrium and ventricle. 1 Mutations that decrease sodium current (I Na ) by disrupting channel processing or function cause a series of overlapping human arrhythmia syndromes, including Brugada Syndrome and conduction system disease. 1, 2 In subjects of Asian ancestry, we have described a common variant in the SCN5A core promoter that modulates the duration of the QRS interval, an index of ventricular conduction, in normal subjects. 3 In addition, the promoter variant appeared to modulate the extent to which drug challenge prolonged QRS in patients with the Brugada Syndrome. Notably, QRS prolongation is a hallmark of sodium channel block by drugs, and sodium channel blockers are well recognized to have proarrhythmic potential. 4 Taken together, these findings implicate variability in SCN5A expression as a mechanism underlying arrhythmia susceptibility in the whole heart. To date, few studies have addressed mechanisms underlying transcriptional control of SCN5A expression. We have previously identified the core promoter of human SCN5A and common polymorphisms in that region. 5, 6 Others have reported that transgenic cardiac expression of the putative repressor Snail led to decreased I Na and dilated cardiomyopathy; further experiments suggested that Scn5a is a Snail target. 7 Snail is zinc-finger transcription factor known to target E-box motifs. 8 Shang and Dudley reported multiple alternate 5Ј-splice variants of the murine sodium channel ortholog; these were developmentally regulated, and both enhancer and repressor regulatory elements and an alternate promoter were identified. 9 In this report, we first identified short sequences highly conserved between mouse and human. Further studies implicated one of these conserved noncoding sequences (CNS), designated CNS28 and located Ϸ1.3 kb upstream of exon 2, as a potential regulator of channel expression. To further test this hypothesis in vivo, we determined the electrophysiological properties of mice in which the CNS28 region was deleted. We find that the absence of CNS28 results in striking increases in sodium channel expression in the intact heart, with attendant increased sodium current and conduction. Additional experiments in heterologous cells and cardiomyocytes implicate the loss of an E-box binding site as responsible for this increase in sodium channel expression.
Methods
Details for each method are presented in the Online Supplement available at http://circres.ahajournals.org.
Identification of Potential Regulatory Regions
To identify CNS elements, we compared the human SCN5A locus with its mouse ortholog using the VISTA Genome Browser (http://pipeline.lbl.gov/cgi-bin/gateway2). 10, 11 Each of 92 CNS elements identified was then PCR amplified and assayed for activity as described below and in the On-Line Supplement. Those showing Ͼ5-fold increase in reporter activity in luciferase assays were then analyzed for potential muscle-specific transcriptional regulatory modules using the M-SCAN algorithm (http://www.cisreg.ca/cgi-bin/mscan/MSCAN). 12, 13 For identification of potential repressive transcription factors in CNS28, we used rVista (http://rvista.dcode.org/) to compare human and mouse sequences for conserved transcription factor-binding sites. 14, 15 
Reporter Constructs
Reporter constructs measuring the activity of all 92 CNS constructs (Online Table I ), human CNS28 with the full-length human SCN5A promoter (Table) , and deletion analysis of the alternate mouse Scn5a promoter (Table) were generated by cloning PCR fragments into the pGL3-promoter or pGL3-basic vectors (Promega). Mutagenesis of the DC3 deletion fragment was performed using the QuickChange XL II kit (Stratagene) using the primers listed in Table. Reporter assays were conducted as previously described in CHO cells 5, 6 and in cardiomyocytes 5, 6, 16 isolated from 1-to 2-day-old mice.
Generation of CNS28 ؊/؊ Mice
We used mouse embryonic stem (ES) cells in which a region of the Scn5a gene was modified to allow recombinase-mediated cassette exchange (RMCE) 17, 18 to be used to easily generate animals containing allelic variants of human sodium channels under control of Scn5a regulatory sequences. Using this approach, we previously generated H/H mice in which the targeted region was replaced by the human SCN5A full-length cDNA. 19 For the present experiments, we modified the original H exchange construct to delete bases 1720 to 2154 (that encompass the CNS28 region), and then performed RMCE as previously described to generate CNS28 ϩ/Ϫ animals. 19 After removal of the hygromycin resistance cassette by breeding to a FlpE-expressing line, mice were then interbred to generate CNS28 Ϫ/Ϫ animals. Experiments began after 3 backcrosses using littermate H/H mice as controls. All experiments performed on mice were approved by the institutional animal care and use committee.
Quantitative Real-Time RT-PCR
Total mRNA from adult mice atria or ventricles was isolated using the TRIzol method (Invitrogen) and cDNA was prepared using the Transcriptor First-Strand cDNA Synthesis kit (Roche). Quantitative real-time RT-PCR (qPCR) on SCN5A was performed with TaqMan probes targeting human SCN5A (Hs00165693_m1) using beta actin (Mm00607939_s1) as a reference gene. The qPCR targeting mouse Scn1b was performed using TaqMan probe (Mm00441210_m1) with Hprt1 (Mm00446968_m1) as the reference gene. Analysis was performed using SDS 2.2.2 software (Applied Biosystems).
Western Blotting
Western blotting protocol and semiquantitative protein analysis are described in the Online Supplement.
ECG (ECG) Recordings and Lidocaine Challenge
ECGs and drug challenges were recorded as previously described. 20
Isolation of Mouse Ventricular Cardiomyocytes and Sodium Current Recordings
Adult H/H and CNS28 Ϫ/Ϫ mouse cardiac ventricular myocytes were isolated by a modified collagenase/protease method, 21 and sodium current studied as previously described. 19 Protocols and data analysis are presented in the Online Supplement.
Echocardiogram
Transthoracic echocardiograms were performed on resting conscious mice at the murine cardiovascular core, Vanderbilt University, as previously described. 22 Signals were acquired using a 15-MHz transducer (Sonos 5500 system, Agilent) and analyzed by a sonographer who was blind to the genotype. 
Nonstandard Abbreviations and Acronyms
DC0-F TGAGGTACCCTTATAGGGGTCACTAATGACATGCC DC1-F TGAGGTACCCCCTTGGCTGACAGGAAGAGAGTGTG DC2-F TGAGGTACCGTGGTAATTAGCGGTGCAGCCTCCT DC3-F TGAGGTACCGTTCTGAATCTTTTGAGGCCACCAGG DC4-F TGAGGTACCAGTCTAGCTAGGGACGGTGCTGC DC-R TCAAGATCTCACAGGCTCTCCTCAGGCTGCCT E-box mutagenesis F ACGTCACACACTTAAGCCTGTTGGAAGTCC R GGACTTCCAACAGGCTTAAGTGTGTGACGT
Atack et al Sodium Channel Regulator

Data Analysis
Results are presented as meanϮSE, and statistical comparisons were made using the unpaired Student t test. A value of PϽ0.05 was considered statistically significant.
Results
Conserved Nucleotide Sequences
In order to identify genomic elements that may play a role in the transcriptional regulation of SCN5A, we compared human and mouse SCN5A sequences to identify conserved regions. Using the genomic sequence comparison program VISTA, we identified 92 CNS elements 77 to 446 base pairs (bp) long with Ͼ70% nucleotide identity between the human locus and its mouse ortholog. We identified 12 out of 92 CNS elements in the 47.7-kb 5Ј upstream region between SCN5A exon 1 and the terminal exon of SCN10A gene, which is just upstream, and 15 of 92 CNS elements were identified in the 26.4-kb 3Ј downstream region between the terminal exon (exon 28) of SCN5A and the exon 1 of the downstream gene ENDOGL1.
The highest density was in intron 1, where 23 CNS elements were contained in 16 kb ( Figure 1A ). Ten introns contained no CNS elements.
We tested the effect of each CNS on the SV40 promoter driving luciferase both in Chinese hamster ovary (CHO) cells and cardiomyocytes. There were 3 elements, CNS23, CNS28 and CNS32, that demonstrated a Ͼ5-fold increase in reporter activity ( Figure 1B) . The MSCAN analysis, which we used to identify potential functionally important clusters of musclespecific transcription factors, designated 3 tandem TEF-1 (transcriptional enhancer factor 1) sites and an SRF (serum response factor) recognition site in CNS28 ( Figure 1C ), and no elements in the other 2. There was a high degree of conservation across species at the SRF and at one of the TEF-1 sites. Accordingly, our further studies focused on the activity of CNS28, a 435-bp region located in the 5Ј portion of intron 1.
Generating CNS28 ؊/؊ Mice
In our previous studies, we replaced a region flanking the endogenous exon 2 transcription site with a construct that contained approximately 2 kb of mouse intron 1 along with the human SCN5A cDNA. In homozygous mice, designated H/H, no murine Scn5a expression was detected; ventricular myocyte sodium current and electrocardiograms (ECGs) were identical to those in wild-type animals, indicating that the human channel generated physiological channel function. 19 In the present experiments, we used site-directed mutagenesis to remove the CNS28 element from our original exchange construct ( Figure 2A ) and then used RMCE to generate CNS28 ϩ/Ϫ mice. Loss of CNS28 was confirmed by (1) and (3), including exon 2 and portions of introns 1 and 2, was previously modified by gene targeting to contain 2 inversely oriented LoxP sites flanking a cassette that contains a neomysin resistant gene and the thymidine kinase (TK) gene. 19 An exchange vector that includes the human SCN5A cDNA flanked by the portions of introns 1 and 2 in the targeted regions was previously used to generate H/H mice. In the present experiment, the exchange vector was modified to remove a 435-bp fragment in intron 1 to generate the CNS28 Ϫ/Ϫ mice. The 5Ј end of CNS28 is located 1361 bp upstream from the start of exon 2. A hygromycin-resistance cassette in the exchanged DNA was removed by breeding to FlpE-expressing animals, leaving a single residual FRT site. B, Genotyping reaction across CNS28 showing H/H, CNS28 ϩ/Ϫ , and CNS28 Ϫ/Ϫ . These lanes were run on the same gel but were noncontiguous. genotyping ( Figure 2B ), and matings of CNS28 ϩ/Ϫ ϫ CNS28 ϩ/Ϫ mice yielded pup distributions in Hardy Weinberg equilibrium with 32 H/H, 64 CNS28 ϩ/Ϫ , and 41 CNS28 Ϫ/Ϫ .
Sodium Channel Expression in CNS28 ؊/؊ Mice
Our initial results indicated that the CNS28 fragment increased SV40-mediated reporter activity. However, in CNS28 Ϫ/Ϫ mouse hearts, quantitative real-time PCR (qPCR) showed that SCN5A transcripts levels were 42%Ϯ12% more abundant in atria and 71%Ϯ23% more abundant in ventricles than in H/H mice (PϽ0.05 in both tissues, Figure 3A and 3B). Western blotting showed concordant results: calnexin-normalized Na v 1.5 abundance in heart was 31%Ϯ10% higher in CNS28 ϩ/Ϫ and 67%Ϯ23% higher in CNS28 Ϫ/Ϫ mice than in H/H mice (PϽ0.05 for both CNS28 ϩ/Ϫ and CNS28 Ϫ/Ϫ when compared with H/H, Figure 3C and 3D) .
These changes translated into increases in functional sodium channels ( Figure 4A and 4B) . Peak I Na amplitude measured at Ϫ30 mV was 59%Ϯ14% greater in CNS28 Ϫ/Ϫ ventricular myocytes in comparison with that in H/H cells (PϽ0.05, Figure 4C ). Interestingly, we also observed small but significant negative shifts in the voltage dependence of sodium channel activation and inactivation in CNS28 Ϫ/Ϫ myocytes ( Figure 4D ).
CNS28 Ϫ/Ϫ mice also showed ECG changes consistent with these findings. In comparison with WT, homozygotes displayed 12.3% shorter PR intervals (38.8Ϯ0.6 ms versus 34.1Ϯ0.7 ms), 9.3% shorter QRS intervals (10.7Ϯ0.2 ms versus 9.7Ϯ0.2 ms), and 7.0% shorter QT intervals (52.9Ϯ0.8 ms versus 49.2Ϯ1.2 ms) (all PϽ0.05, Figure 4E ). After challenge with the sodium channel blocker lidocaine, these intervals increased to a similar absolute extent in both genotypes, prolonging PR by 14.1 and 13.9 ms and QRS by 4.1 and 3.2 ms in H/H and CNS28 Ϫ/Ϫ , respectively. Flecainide challenge showed similar results (data not shown).
In Vitro Transcriptional Regulation by CNS28
The finding that deleting CNS28 increased channel transcripts and protein, with functional consequences, indicates that this region includes sequences that suppress sodium channel expression in vivo. This result is at odds with the initial screening experiment that identified CNS28 as a potential positive regulatory sequence. On the basis of these results we assessed reporter activity of constructs in which human CNS28 was included with the full-length SCN5A promoter 6 rather than the SV40 promoter used in the initial experiments. We compared activity of 2 constructs, each containing the SCN5A promoter and luciferase, 1 with and 1 without CNS28 ( Figure 5A ). The construct without CNS28 increased luciferase expression 33%Ϯ4% in CHO cells and 87%Ϯ35% in myocytes ( Figure  5B and 5C, both PϽ0.05), consistent with the repressor function indicated by the in vivo findings.
We have previously identified a region upstream of exon 1 as the core SCN5A promoter. 5, 6 Experiments conducted by Shang and Dudley revealed a second, 1363-bp Scn5a promoter in the mouse. 9 The 5Ј 435 bp of this promoter are what we identified in our screen as CNS28. Their analysis suggested that the 5Ј 480 bp contained a repressive element. 9 We hypothesized that CNS28 contained this repressive activity and generated a series of smaller deletions of the alternative promoter that they described ( Figure 6A ). The rVista analysis identified 30 possible transcription factor-binding sites conserved between the human and mouse, and therefore break points were chosen between clusters of these sites (Online Figure I) . The full alternative promoter-luciferase construct (1,361 bp) was designated deletion construct 0 (DC0), and contains all the features of the Shang and Dudley promoter stated above. Deletion construct 1 (DC1) removes the initial 50 bp and deletion construct 2 (DC2) an additional 100 bp. Deletion construct 3 (DC3) eliminates 285 bp of the alternate promoter.
Deletion construct 4 (DC4) takes away the entirety of CNS28 from the alternate promoter by deleting the first 435 bp.
In our luciferase reporter assay, the activity of DC0 was used as the baseline reference in both CHO cells and myocytes. Constructs DC1 and DC2 showed no difference in activity versus DC0 in either cell type. The DC3 construct virtually abolished reporter activity in both cell types, reducing activity to 3.3%Ϯ0.1% of DC0 in CHO cells, and 12%Ϯ3% in myocytes (both PϽ0.05). The last construct, DC4, restored activity to 79%Ϯ6% and 67%Ϯ11% of DC0 in CHO cells and myocytes, respectively ( Figure 6B and 6C, both PϽ0.05). There are 2 points illustrated by these data. First, between DC2 and DC3 there is likely an enhancer element that can counter the negative transcriptional activity we observe with CNS28; therefore, DC3 shows the highest repressive activity. Second, removal of 150 base pairs between DC3 and DC4 results in loss of that repressive activity. Sequence analysis of this region shows that it contains an E-box motif (consensus sequence CANNTG). 23 The repressor Snail has previously been shown to bind E-boxes in the core promoter of SCN5A. 7 Therefore we tested the hypothesis that this E-box may be important for repressor binding. When the motif was mutated in DC3 (CATATG to CTTAAG), activity was restored to 62%Ϯ4% of the activity of DC0 in CHO cells and 66%Ϯ10% in myocytes ( Figure 6D and 6E, both PϽ0.05) . This increase in activity is similar to the increase we see between DC3 and DC4, in which the final segment containing the E-box is removed, further supporting our hypothesis. Luciferase activity driven by the full-length human SCN5A promoter with and without CNS28 in CHO cells (B) and neonatal cardiomyocytes (C). SCN5A promoter with CNS28 is designated 100% activity. When CNS28 is not present, luciferase activity increases by 33%Ϯ4% in CHO cells and 87%Ϯ35% in myocytes. *PϽ0.05.
Discussion
Sodium Channels Are Required for Normal Cardiac Function
Na v 1.5 expression is absolutely required for normal cardiac function; knockouts in mice and in fish are embryolethal and cause cardiac developmental abnormalities. 24, 25 More modest reduction of sodium current slows cardiac conduction and creates an arrhythmia-prone heart in the setting of monogenic disease 26, 27 or during therapy with sodium channel-blocking drugs. 4 We have previously found an association between a variant haplotype in a regulatory region of the cardiac sodium channel promoter commonly observed in Asian subjects and variable QRS duration, and recent genome-wide association studies have identified an association between the SCN5A-10A locus and variable PR and QRS durations. 28 -30 These data support the general hypothesis 31,32 that variable cardiac ion channel transcription modulates the electrophysiological properties of the heart. A contrary view is that feedback mechanisms in the mammalian heart regulate transcription to achieve a tight range of normal electrophysiological behaviors, 32 although monogenic diseases producing striking electrocardiographic changes argue against such tight control. Previous work in this area has focused on in vitro approaches and on establishing the functional consequences of coding region variants in genetically modified mice. However, no study to date has directly evaluated the functional consequences of deleting noncoding potential regulatory regions of a cardiac ion channel gene.
CNS28 Regulates Cardiac Sodium Channel Expression
Our initial in silico screen identified 92 highly conserved noncoding sequences, and preliminary reporter experiments, using the SV40 promoter, suggested that one, CNS28, included positive regulatory elements for SCN5A. Driven by this initial result, we generated CNS28 Ϫ/Ϫ mice, and unexpectedly, these animals demonstrated dramatic increases in sodium channel transcripts and channel protein expression. This increased Na v 1.5 is functional: the CNS28 Ϫ/Ϫ mice have significantly larger peak I Na in isolated ventricular myocytes and shorter PR and QRS, indicating rapid ventricular conduction. The increased sodium current also displayed unexpected shifts in the voltage dependence of channel activation and inactivation; the mechanism requires further study, but one possibility is a change in the extent of interaction with ancillary proteins, such as ␤-subunits, that are known to modulate channel gating. 33 For example, using real-time PCR, we found no alterations in expression of Scn1b in CNS28 Ϫ/Ϫ mouse hearts (Online Figure II) . This supports the notion that although more sodium channels are present, concomitant increases in function modifying protein partners may not occur. Changes in the Na V 1.5 macromolecular complex could lead to alteration in channel gating. Further experiments examining changes in expression and localization of other Na V 1.5 partners 34 may assist in elucidating the underlying mechanism. Another possibility is raised by the clustering of Scn5a with Scn10a and 11a in the mouse and human genomes; thus, it is conceivable that removal of CNS28 impacts the level of expression of these channels in the heart. Such a change in the channel profile in the heart could result in shifts in the inactivation and activation of cardiac sodium current. However, in preliminary experiments we observe no change in Scn11a expression in the 2 lines and have been unable to amplify Scn10a, suggesting that this channel is not abundantly expressed in the heart. Importantly, heart wall measurements, examination of contractile function (Online Table II ), and survival rates were no different in CNS28 Ϫ/Ϫ mice than they were in H/H animals.
Molecular Basis for CNS28 Activity
Our study identified a 435-bp segment of DNA whose deletion increases channel expression, and reporter experiments using the more physiologically relevant SCN5A promoter are consistent with this result. Our analysis of deletion constructs demonstrates that a repressor element lies within a 226-bp fragment at the 3Ј end of CNS28. The 5 binding sites conserved between mouse and human in this region identified by rVista include E47, E12, E2A, MYOD, and T3R. None of these factors are good candidates to act as a repressor. However, in the 226-bp segment, we also identified a single E-box motif in the mouse and 2 in the human. Mice overexpressing Snail, which binds E-box sites in the SCN5A core promoter, exhibit a reduction in Scn5A transcript and protein. 7 We observed an increase in luciferase expression following mutation of the E-box, arguing that this motif is critical for repression of SCN5A. E-boxes are typically bound by basic helix-loop-helix factors, such as HAND proteins. 23 However, given the previous studies linking Snail to SCN5A, our work raises the possibility that the CNS28 E-box is a Snail-binding region and that this interaction is needed in vivo to regulate SCN5A transcript levels.
Limitations
One limitation of our study is that in order to identify elements relevant to SCN5A transcription, we choose to examine highly conserved elements between the mouse and human and replace the mouse Scn5a allele with a human SCN5A. However, in the animals we generated, potential mouse regulatory sequences, including the core promoter, are intact, and therefore the effects we see following deletion of CNS28 are in the murine context and may or may not apply to humans. However, E-boxes are evolutionarily conserved in both mouse and human promoter regions and so likely have similar functions in both species.
Summary
We hypothesize that increased sodium channel expression should translate to protection against arrhythmias that are mediated by decreased sodium channel function; settings in which this mechanism is thought to be operative include acute ischemia, especially with sodium channel block 4 and the Brugada Syndrome. 3, 25, 35 As a first test of this hypothesis, we examined the extent to which challenge with a sodium channel blocker slowed conduction in H/H and CNS28 Ϫ/Ϫ mice. In this experiment, both lidocaine and flecainide prolonged PR and QRS to a similar extent; thus, with drug challenge, absolute conduction times remained shorter in the CNS28 Ϫ/Ϫ animals. The further elucidation of mechanisms affecting SCN5A transcription may point to entirely novel ways in which to intervene to stabilize cardiac electrophysiological activity.
